Artificial intelligence has helped map the hidden biology behind the pain, dizziness, and exhaustion of chronic fatigue syndrome, and identified new biomarkers to improve diagnosis.

A newly discovered “neurobiotic sense” reveals how gut cells listen to microbial chatter and signal the brain to influence hunger, cravings, and behavior. 

Professor Emeritus of Pediatrics Dennis Clements, MD, PhD, who retired on June 30, shares the stories behind some of the objects in his office that trace his 50 years at Duke.

A new algorithm could help researchers better predict how molecules bind to proteins —an essential step in designing more effective drugs to treat a wide range of diseases.

Researchers at Duke Cancer Institute, working with a health technology company, have developed an AI-powered biomarker that could help determine which patients need extended hormone therapy and which could safely avoid it.

A Duke Health team led by Joseph Turek, MD, PhD, performed the world's first on-table heart reanimation for infant transplant, an advance that could dramatically expand the donor pool for pediatric heart transplants.

A team led by Thuy Le, MD, PhD, associate professor of medicine and global health, developed a tool that significantly improves the speed and accuracy of diagnosis for a rare fungal disease called talaromycosis.

In this conversation, Dean Klotman and Matthew Barber, MD, president of the Duke Health Integrated Practice (DHIP) and vice dean for clinical affairs, reflect on DHIP’s two-year anniversary. They highlight its role in unifying Duke Health’s clinical, academic, and community missions.

As expensive new weight loss medicines Wegovy and Mounjaro shake up obesity treatment, the Duke study provides a reminder of the lasting savings surgery can deliver. 

Research led by Virginia Byers Kraus, MD, PhD, indicates that key proteins in the ankles are similar to those used by salamanders to regenerate severed limbs and might hold the key to a new therapeutic approach for joint disease.